Overview

Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to - compare the single dose bioavailability of Simvastatin 80 mg tablets with ZocorĀ® 80 mg tablets of MercK & Co. Inc, USA in healthy subjects under fasting conditions - monitor adverse events and to ensure the safety of subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Simvastatin